Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00291564 · ClinicalTrials.gov registry record
Ensure Cardiac Resynchronization Therapy Study
A clinical trial, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- 430
- Enrollment target
NCT00291564 is a clinical trial that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 430 participants.
The verdict
NCT00291564 has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- 430 participants
- Enrollment target
Study Summary
The purpose of this study is to gather information on how doctors program particular settings on cardiac resynchronization therapy implantable cardiac defibrillators (CRT-Ds), to analyze how these settings affect the amount of cardiac resynchronization therapy (CRT) patients receive and to evaluate the therapy approach for converting abnormally fast heartbeats into normal heartbeats. There are no experimental devices or procedures involved in this study.
Interventions
- DEVICE Cardiac Resynchronization Therapy Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 430 participants |
| Start Date | 2004-05 |
| Est. Completion | 2006-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00291564
The ClinicalTrials.gov registry entry for NCT00291564 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 430 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cardiac Resynchronization Therapy Device is the first listed.
NCT00291564 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00291564 about?
NCT00291564 is a clinical study titled "Ensure Cardiac Resynchronization Therapy Study". The purpose of this study is to gather information on how doctors program particular settings on cardiac resynchronization therapy implantable cardiac defibrillators (CRT-Ds), to analyze how these settings affect the amount of cardiac resynchronization therapy (CRT) patients receive and to evaluate ...
What is the current status of trial NCT00291564?
This trial is currently completed. The enrollment target is 430 participants. The study started on 2004-05. Estimated completion is 2006-02.
What interventions are being tested in trial NCT00291564?
The interventions under investigation include: Cardiac Resynchronization Therapy Device (DEVICE).
Who is sponsoring clinical trial NCT00291564?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.